Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: Cancer Immunol Res. 2020 Mar 16;8(5):648–659. doi: 10.1158/2326-6066.CIR-19-0647

Table 2.

TCR V gene and CDR3 amino acid sequences of HLA-A*03:01–restricted MCPyV-specific CD8+ T-cell clones.

MCPyV epitope clono-type TRBV beta CDR3 TRAV alpha CDR3 no of clones (%) EC50ng/ml TRB CDR3 frequency, rank in tumor
CT AA 32–40 1 19*00 CASSQGFGANVLTF 12–1*00 CVVNGNNNDMRF 9/19 (47%) 7.6 0.81%,11
2 19*00 CASVSGQGVSPLHF 12–1*00 CVVNNNNNDMRF 2/19 (11%) 23.6 0.17%, 49
3 15*00 CATSRDGAGLVNQPQHF 25*00 CAGARNDYKLSF 2/19 (11%) 23.4 0.87%, 7
4 4–3*00 CASSQDPGSSYNEQFF 38–1*00 CALATHTGTASKLTF 4/19 (21%) 12.4 0.02%, 527
5 7–6*00 CASSLNPGRSDSPLHF 27*00 CAGAIPRDDKIIF 2/19 (11%) 22.1 0.19%, 44
35*00 CAGHSGNTPLVF 2/19 (11%)
LT AA 95–103 1 4–3*00 CASSPNPQGANMDTQYF 3*00 CAVRALGNAGNMLTF 8 of 9 1.9 0.1%, 75